Clinicians may delay dose escalation, maintain a current dose longer than 4 weeks, return to a previously tolerated dose, or temporarily interrupt treatment if patients experience significant side effects
There are two compartment-specific BCAA transaminases in humans, BCAT1 (or cBCAT), which is located in the cytoplasm and primarily expressed in the brain, and BCAT2 (or mBCAT), which is located in mitochondria with ubiquitous expression
We can reduce these effects by starting with a low dose and eating a light meal before use
These smaller lesions are called satellite lesions
Based on application, it is categorized into functional drinks, medicine, healthcare products, and animal food